| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/22/2011 | WO2011160064A1 Digital holographic method of measuring cellular activity and of using results to screen compounds |
| 12/22/2011 | WO2011160048A2 Methods of identifying therapeutic agents for treating persister and bacterial infection |
| 12/22/2011 | WO2011160042A2 Prpk-tprkb modulators and uses thereof |
| 12/22/2011 | WO2011160015A2 Rotors for immunoassays |
| 12/22/2011 | WO2011159847A2 Receptor tyrosine kinase-like orphan receptor 1 (ror1) single chain fv antibody fragment conjugates and methods of use thereof |
| 12/22/2011 | WO2011159835A1 Antibodies to endoplasmin and their use |
| 12/22/2011 | WO2011159797A2 A compendium of ready-built stem cell models for interrogation of biological response |
| 12/22/2011 | WO2011159789A2 Tritiated planar carbon forms |
| 12/22/2011 | WO2011159750A1 Biomarkers for the treatment of psoriasis |
| 12/22/2011 | WO2011159741A2 Tetranor-pgem/pgam specific immunogens, antibodies, tracers, assay kits and methods for making same |
| 12/22/2011 | WO2011159735A2 Tetranor-pgdm/pgjm specific immunogens, antibodies, tracers, assay kits and methods for making same |
| 12/22/2011 | WO2011159721A2 System and method for magnetically concentrating and detecting biomarkers |
| 12/22/2011 | WO2011159707A1 Magnetic beads for reducing leukocyte interference in immunoassays |
| 12/22/2011 | WO2011159676A2 In-situ identification and control of microstructures produced by phase transformation of a material |
| 12/22/2011 | WO2011159658A2 Methods,assays, and kits related to dichloroacetate (dca) |
| 12/22/2011 | WO2011159560A1 Apparatus and method for replicating liquid blends and identifying the ratios of their liquid ingredients |
| 12/22/2011 | WO2011159537A2 Method and device for analyte detection |
| 12/22/2011 | WO2011159529A1 Method for non-covalent immobilization of infectious prion protein |
| 12/22/2011 | WO2011159318A1 Sensor including a photocatalyst |
| 12/22/2011 | WO2011159304A1 Non-invasive compressibility and in situ density testing of a fluid sample in a sealed chamber |
| 12/22/2011 | WO2011159054A2 Method for identifying proper storage of goods requiring storage at low temperature |
| 12/22/2011 | WO2011159004A1 Snp for predicting the sensitivity to anticancer targeted therapeutic formulation |
| 12/22/2011 | WO2011159000A1 Human monoclonal antibody that binds specifically with oxidized low-density lipoprotein and carbamylated low-density lipoprotein, and antigen-binding fragment thereof |
| 12/22/2011 | WO2011158973A1 Novel antifibrin antibody |
| 12/22/2011 | WO2011158883A1 Antibody capable of determination of cancer prognosis, and cancer prognosis determination method |
| 12/22/2011 | WO2011158847A1 Kit for detection of gene targeted by microrna, and method for detection of gene targeted by microrna |
| 12/22/2011 | WO2011158798A1 Method for observation and early prediction of clinical course of therapeutic effect on psoriasis, and kit for use in the method |
| 12/22/2011 | WO2011158769A1 Marker for detection and/or discrimination of non-alcoholic steatohepatitis, method for detection and/or discrimination of non-alcoholic steatohepatitis, and kit for use in the method |
| 12/22/2011 | WO2011158759A1 Production device, production method, antibody chip, programme, and recording medium |
| 12/22/2011 | WO2011158736A1 Method for high-speed and high-sensitivity molecule detection/quantification via charge measurement using power generation enzyme, and detection part and device to be used for the method |
| 12/22/2011 | WO2011158655A1 Use with utilization of soluble klotho-, fgf23- and fgfr-complex formation mechanism in calcified tissue |
| 12/22/2011 | WO2011158590A1 Liver disease marker, method and apparatus for measuring same, and test method for pharmaceutical preparation |
| 12/22/2011 | WO2011158246A1 An apparatus and method for detecting biological state in a sample using biomarkers |
| 12/22/2011 | WO2011158200A1 Non covalent molecular structure, device comprising the same and its use for the detection of a lectin |
| 12/22/2011 | WO2011158192A1 Method for characterising an agri-food product and device for implementing such a method |
| 12/22/2011 | WO2011158178A1 Use of dronedarone for the preparation of a medicament for use in the treatment of patients |
| 12/22/2011 | WO2011158174A1 Multi epitope assay |
| 12/22/2011 | WO2011158151A1 System and method for determining the phase envelope of a gas condensate |
| 12/22/2011 | WO2011158068A1 Non covalent molecular structure, device comprising the same and its use for detection of lectin |
| 12/22/2011 | WO2011158025A1 In vitro bone model and distraction device |
| 12/22/2011 | WO2011157894A2 Device for simulation |
| 12/22/2011 | WO2011157817A1 Detection of antigen-specific peripheral blood mononuclear cells and methods for diagnosing immune disorders |
| 12/22/2011 | WO2011157801A1 Method for detecting peroxide explosives |
| 12/22/2011 | WO2011157767A1 Integrated optical waveguide evanescent field sensor |
| 12/22/2011 | WO2011157756A1 Prediction and recognition of acute kidney injury after surgery |
| 12/22/2011 | WO2011157738A1 Sampling and analysis method to achieve a detailed analysis of a reactor effluent |
| 12/22/2011 | WO2011157678A1 Method for determination of target cells or tissue for extraction of biomolecules from fixed biological samples |
| 12/22/2011 | WO2011157655A1 Use of bile acids for prediction of an onset of sepsis |
| 12/22/2011 | WO2011157625A1 Method and apparatus for testing ceramic components having the ability to withstand high temperatures |
| 12/22/2011 | WO2011157584A1 Legionella test |
| 12/22/2011 | WO2011157446A1 Biomarkers for the prediction of incident cancer |
| 12/22/2011 | WO2011157445A1 Markers for the prognosis and risk assessment of pregnancy-induced hypertension and preeclampsia |
| 12/22/2011 | WO2011157443A1 (11b,17a)-11-(4-(2-11c-acetyl)phenyl)-17,23-epoxy-19,24-dinorchola-4,9,20-trien-3-one |
| 12/22/2011 | WO2011157222A1 Joint detection methods for lymphoma fusion genes and diagnostic kits thereof |
| 12/22/2011 | WO2011156852A1 Genetic analysis loc with non-specific nucleic acid amplification section and subsequent specific amplification of particular sequences in a separate section |
| 12/22/2011 | WO2011156851A1 Test module with diffusive mixing in small cross section area microchannel |
| 12/22/2011 | WO2011156850A1 Microfluidic device with pcr section and diffusion mixer |
| 12/22/2011 | WO2011156847A1 Microfluidic device for genetic and mitochondrial analysis of a biological sample |
| 12/22/2011 | WO2011156845A1 Loc device with parallel incubation and parallel dna and rna amplification functionality |
| 12/22/2011 | WO2011156844A1 Loc device for genetic analysis which performs nucleic acid amplification before removing non-nucleic acid constituents in a dialysis section |
| 12/22/2011 | WO2011156843A1 Loc device for genetic analysis which performs nucleic acid amplification after sample preparation in a dialysis section |
| 12/22/2011 | WO2011156841A1 Loc device for pathogen detection with dialysis, thermal lysis, nucleic acid amplification and prehybridization filtering |
| 12/22/2011 | WO2011156840A1 Loc device for pathogen detection and genetic analysis with chemical lysis, incubation and tandem nucleic acid amplification |
| 12/22/2011 | WO2011156839A1 Loc device for genetic analysis with dialysis, chemical lysis and tandem nucleic acid amplification |
| 12/22/2011 | WO2011156838A1 Loc device for pathogen detection with dialysis, chemical lysis and tandem nucleic acid amplification |
| 12/22/2011 | WO2011156837A1 Loc device for pathogen detection with dialysis, thermal lysis, nucleic acid amplification and prehybridization filtering |
| 12/22/2011 | WO2011156835A1 Test module incorporating spectrometer |
| 12/22/2011 | WO2011130273A3 Optimized oligonucleotides associated with prostate cancer associated viruses and host biomarkers |
| 12/22/2011 | WO2011130184A3 SYSTEMS AND METHODS FOR MODEL-BASED qPCR |
| 12/22/2011 | WO2011128357A3 Biomarkers for hypertensive disorders of pregnancy |
| 12/22/2011 | WO2011123785A3 Frizzled-binding agents and uses thereof |
| 12/22/2011 | WO2011100426A3 Compositons and methods for predicting cardiovascular events |
| 12/22/2011 | WO2011100408A3 Serologic correlates of protection against bacillis anthracis infection |
| 12/22/2011 | WO2011100358A3 Systems and methods for detecting target analytes |
| 12/22/2011 | WO2011100057A3 Methods and compositions for universal detection of nucleic acids |
| 12/22/2011 | WO2011097561A3 Methods and systems for fluid examination and remediation |
| 12/22/2011 | WO2011097327A3 Compositions and methods of modulating receptor protein tyrosine phosphatases |
| 12/22/2011 | WO2011094671A3 N-terminally conjugated polypeptides for targeted therapy and diagnosis |
| 12/22/2011 | WO2011094584A3 Method and system for purifying and quantitating proteins using heme fusion tags |
| 12/22/2011 | WO2011094535A3 Biomarkers of aging for detection and treatment of disorders |
| 12/22/2011 | WO2011094483A3 Immune gene signatures in cancer |
| 12/22/2011 | WO2011091007A3 Cell counting and sample chamber and methods of fabrication |
| 12/22/2011 | WO2011088026A3 Biomarkers of liver injury |
| 12/22/2011 | WO2011085057A3 Methods for detecting insulin autoantibody |
| 12/22/2011 | WO2011081421A3 Complement c9 as markers for the diagnosis of cancer |
| 12/22/2011 | WO2011078650A3 Method for fabricating nanofluidic channels |
| 12/22/2011 | WO2011067450A3 Covalently biofunctionalized supports |
| 12/22/2011 | WO2011066458A3 Novel genomic biomarkers for irritable bowel syndrome diagnosis |
| 12/22/2011 | WO2010106347A8 Biomolecular labelling using multifunctional biotin analogues |
| 12/22/2011 | WO2010089115A8 Multispecific peptides |
| 12/22/2011 | WO2010087991A3 Methods for diagnosing impending joint failure |
| 12/22/2011 | WO2010075333A8 Organic chemical sensor with microporous organosilicate material |
| 12/22/2011 | US20110314573 Screening method for identifying genes involved in plant cell cycle |
| 12/22/2011 | US20110314569 Combination of Two Genetic Elements for Controlling the Floral Development of a Dicotyledonous Plant, and Use in Detection and Selection Methods |
| 12/22/2011 | US20110313681 Biomarkers for peripheral artery disease |
| 12/22/2011 | US20110313677 Method for determining the liver performance of a living organism by the means of quantitative measuring the metabolization of substrates |
| 12/22/2011 | US20110313675 Rapid diagnosis of a disease condition using infrared spectroscopy |
| 12/22/2011 | US20110313673 Methods and apparatus for decentralized diabetes monitoring |
| 12/22/2011 | US20110313276 Non-invasive in vitro method for quantifying liver lesions |
| 12/22/2011 | US20110313147 Chromatographic material for the absorption of proteins at physiological ionic strength |